ARTS-II Data Will Drive Multi-Vessel Stenting Payment Push – Cordis
This article was originally published in The Gray Sheet
Executive Summary
Results from the ARTS-II trial comparing drug-eluting stents with bypass surgery will support stent makers' efforts to obtain a higher Medicare payment rate for stenting patients with multi-vessel coronary disease, according to Johnson & Johnson/Cordis